This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Wistar Institute, University of Pennsylvania. Active years: 2013.
Company Filing History:
1 out of 246 
1 out of 2,645 
Years Active: 2013
Title: Innovations of Malik Yousef in Lung Cancer Diagnosis
Introduction
Malik Yousef is a notable inventor from Dabburiya Village, IL, recognized for his significant contributions to the field of medical diagnostics. He holds a patent that focuses on a method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells. This innovative approach has the potential to enhance early detection and improve patient outcomes in lung cancer treatment.
Latest Patents
Malik Yousef's patent, titled "Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells," presents methods and compositions for diagnosing lung cancer in mammalian subjects. The patent outlines the use of three or more selected genes from the peripheral blood mononuclear cells of the subject, which are characteristic of the disease or its stage. The gene expression profile includes genes from specified tables, and the detection of changes in expression is correlated with non-small cell lung cancer (NSCLC). The patent also describes compositions for diagnosis, including PCR primer-probe sets and immobilized polynucleotides.
Career Highlights
Throughout his career, Malik Yousef has worked with prestigious institutions such as The Wistar Institute of Anatomy & Biology and the University of Pennsylvania. His work in these organizations has contributed to advancements in cancer research and diagnostics.
Collaborations
Malik Yousef has collaborated with notable colleagues, including Michael Showe and Louise C Showe, who have contributed to his research endeavors.
Conclusion
Malik Yousef's innovative work in lung cancer diagnostics exemplifies the impact of research and invention in the medical field. His patent represents a significant step forward in the early detection of lung cancer, potentially saving lives through improved diagnostic methods.